| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 17.9 | Jun 30, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.3333 | Mar 31, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.3333 | Mar 31, 2025 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Mar 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Mar 31, 2025 | Active | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 16.3517 | Dec 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.225 | Dec 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.225 | Dec 31, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 19.9888 | Sep 30, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 19.9888 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.4 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.4 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.4 | Sep 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.0975 | Jun 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 25.85 | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 25.85 | Mar 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.1548 | Mar 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.1548 | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 28.35 | Dec 31, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 28.35 | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.1173 | Dec 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.1173 | Dec 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.1173 | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 24.95 | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.5923 | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 64.1667 | Jun 30, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 64.1667 | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.9833 | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 6.9833 | Jun 30, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Radium (-226 and -228) | Health-Based | N/A | 5.74 | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 5.74 | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 5.74 | Jun 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 80.5 | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 87.5 | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 91.5 | Jun 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 91.5 | Jun 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 101.75 | Mar 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 101.75 | Mar 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 101.75 | Mar 31, 2021 | Resolved | N/A |